Human Mixtard 40 IU/ml is a biphasic isophane insulin suspension for injection.
- Active Ingredients: It contains 30% soluble (short-acting) human insulin and 70% isophane (intermediate-acting) human insulin.
- Mechanism of Action: The short-acting component begins working within approximately 30 minutes to manage post-meal glucose spikes, while the intermediate-acting component provides prolonged glucose control for up to 24 hours, covering basal needs between meals and overnight.
The primary use of Human Mixtard 40 IU/ml is the treatment of diabetes mellitus in adults and children.
- Blood Sugar Control: It helps maintain stable blood glucose levels throughout the day.
- Complication Prevention: By effectively managing glucose levels, it reduces the risk of long-term diabetes complications such as kidney damage, eye damage (retinopathy), nerve problems (neuropathy), and loss of limbs.




Reviews
There are no reviews yet.